|
|
Volumn 18, Issue 12, 1993, Pages 1129-1136
|
|
Lipophilic GABA uptake inhibitors: Biochemistry, pharmacology and therapeutic potential
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (4,4 DIPHENYL 3 BUTENYL)GUVACINE;
1 (4,4 DIPHENYL 3 BUTENYL)NIPECOTIC ACID;
1 [2 [4,4' BIS(TRIFLUOROMETHYL)BENZHYDRYLOXY]ETHYL] 1,2,5,6 TETRAHYDRO 3 PYRIDINECARBOXYLIC ACID;
4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
GUVACINE;
NIPECOTIC ACID;
NNC 05 0711;
PHENOBARBITAL;
PHENYTOIN;
TIAGABINE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTICONVULSANT ACTIVITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
EPILEPSY;
GABAERGIC SYSTEM;
GLIA CELL;
HUMAN;
HUMAN EXPERIMENT;
INTRAPERITONEAL DRUG ADMINISTRATION;
MEMORY;
MOUSE;
NERVE CELL;
NEUROTOXICITY;
NEUROTRANSMISSION;
NONHUMAN;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RAT;
REVIEW;
SYNAPTOSOME;
|
|
EID: 0027753878
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.1993.018.12.233950 Document Type: Review |
|
Times cited : (22)
|
|
References (0)
|
